QA: Pardes Biosciences INC in us_pharma/2021

Table of Contents

See also this year's filing and all EDGAR filings for this company.

PDF Report 0001822711_2022_Pardes_Biosciences_INC.pdf

Logs

warning The stock price does not exist industry.us_generic {}

Graph

Absolute values for 0001822711, Pardes Biosciences INC

  xvar xval
0 AssetsCurrent 275,259,000
1 IntangibleAssetsNetIncludingGoodwill 0
2 PropertyPlantAndEquipmentNet 0
3 remainder_Assets 0
4 LiabilitiesCurrent 8,965,000
5 LiabilitiesNoncurrent 0
6 remainder_Liabilities 0
7 CostOfGoodsAndServicesSold 0
8 SellingGeneralAndAdministrativeExpense 10,336,000
9 ResearchAndDevelopmentExpense 28,152,000
10 remainder_Expenses 30,000
11 remainder_Revenues 0
12 remainder_NetIncome 0
13 remainder_ComprehensiveNetIncome 0
  yvar yval
0 Assets 275,259,000
1 Liabilities 8,965,000
2 Expenses 38,518,000
3 Revenues 0
4 StockholdersEquity 266,294,000
5 NetIncome -38,518,000
6 ComprehensiveNetIncome -38,518,000
7 BaseVar 161,371,000
8 EconomicCapitalRatiobeforeLimitedLiability 3.81
9 EconomicCapitalRatio 4.25

Edgar->Model Mapping

Feature Distribution